Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Arjun Ravi (Greater Manchester, United Kingdom), Arjun Ravi, Jonathan Plumb, Jonathan Lemon, George Booth, Jorgen Vestbo, Dave Singh. Impaired monocyte chemotaxis in COPD. Eur Respir J 2015; 46: Suppl. 59, 375

Member's Comments

No comment yet.

Related content which might interest you: Monocyte sub-populations do not reflect differences in COPD macrophage phenotype Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Elevated GM-CSF in COPD may drive defective macrophage phenotype Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Oxidative stress drives defective efferocytosis in COPD M2-like macrophages Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Effect of JQ-1 on monocyte-derived macrophage (MDM) phagocytosis of bacteria and cytokine release Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Increased expression of sphingosine-1-phosphate and S1PR2 are associated with attenuated macrophage phagocytosis in COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Macrophage phenotype does not affect protease anti-protease imbalance in COPD Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Monocyte-derived macrophages from non-smoker COPD subjects exhibit defective bacterial phagocytosis Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 IL32 expression in induced sputum of COPD subjects Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Impaired HGF-production by alveolar macrophages is a feature of diabetic pneumonia Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Characterization of M1 and M2 macrophages in human lung tissue Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 The role of monocyte derived growth factors in BPD development Source: International Congress 2016 – Origins of infant pulmonary disease: early pointers for identifying infants at risk and ways to improve their care Year: 2016 Increased susceptibility of M2 monocyte-derived macrophages from COPD patients to oxidative stress Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Dual role of M2 macrophages in asthma Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Biomass smoke particles induce cytokines and reduce phagocytosis by monocyte-derived macrophages Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Differential sensitivity of subsets of monocyte-derived macrophages to apoptosis; its impact on lung inflammation Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Role of 15-lipoxygenase in the polarization of human lung macrophages Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Macrophage subsets in lung tissue of healthy controls and asthma patients Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Distinct localization of estrogen receptors in lungs of severe COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015